Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG: The spectrum of neuromyelitis optica. Lancet Neurol. 2007, 6: 805-815. 10.1016/S1474-4422(07)70216-8.
Article
CAS
PubMed
Google Scholar
Pittock SJ: Neuromyelitis optica: A new perspective. Seminars in neurology. 2008, 1: 95-104. 10.1055/s-2007-1019131.
Article
Google Scholar
Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG: The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999, 53: 1107-1114.
Article
CAS
PubMed
Google Scholar
Papeix C, Vidal JS, de Seze J, Pierrot-Deseilligny C, Tourbah A, Stankoff B, Lebrun C, Moreau T, Vermersch P, Fontaine B, Lyon-Caen O, Gout O: Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler. 2007, 13: 256-259. 10.1177/1352458506070732.
Article
CAS
PubMed
Google Scholar
Watanabe S, Misu T, Miyazawa I, Nakashima I, Shiga Y, Fujihara K, Itoyama Y: Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis. Mult Scler. 2007, 13: 968-974. 10.1177/1352458507077189.
Article
CAS
PubMed
Google Scholar
Watanabe S, Nakashima I, Misu T, Miyazawa I, Shiga Y, Fujihara K, Itoyama Y: Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. Mult Scler. 2007, 13: 128-132. 10.1177/1352458506071174.
Article
CAS
PubMed
Google Scholar
Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C: An open label study of the effects of rituximab in neuromyelitis optica. Neurology. 2005, 64: 1270-1272.
Article
CAS
PubMed
Google Scholar
Jacob A, Weinshenker BG, Violich I, McLinskey N, Krupp L, Fox RJ, Wingerchuk DM, Boggild M, Constantinescu CS, Miller A, De Angelis T, Matiello M, Cree BA: Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients. Arch Neurol. 2008, 65: 1443-1448. 10.1001/archneur.65.11.noc80069.
Article
PubMed
Google Scholar
Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE, Lassmann H: A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain. 2002, 125: 1450-1461. 10.1093/brain/awf151.
Article
PubMed
Google Scholar
Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG: A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004, 364: 2106-2112. 10.1016/S0140-6736(04)17551-X.
Article
CAS
PubMed
Google Scholar
Jarius S, Aboul-Enein F, Waters P, Kuenz B, Hauser A, Berger T, Lang W, Reindl M, Vincent A, Kristoferitsch W: Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain. 2008, 131: 3072-3080. 10.1093/brain/awn240.
Article
CAS
PubMed
PubMed Central
Google Scholar
Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, Watanabe S, Shiga Y, Kanaoka C, Fujimori J, Sato S, Itoyama Y: Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain. 2007, 130: 1235-1243. 10.1093/brain/awm062.
Article
PubMed
Google Scholar
Matsuoka T, Matsushita T, Kawano Y, Osoegawa M, Ochi H, Ishizu T, Minohara M, Kikuchi H, Mihara F, Ohyagi Y, Kira J: Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain. 2007, 130: 1206-1223. 10.1093/brain/awm027.
Article
PubMed
Google Scholar
Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG: Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006, 66: 1485-1489. 10.1212/01.wnl.0000216139.44259.74.
Article
CAS
PubMed
Google Scholar
McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS: Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001, 50: 121-127. 10.1002/ana.1032.
Article
CAS
PubMed
Google Scholar
Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, Watanabe S, Ishii N, Itoyama Y: Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica. Tohoku J Exp Med. 2006, 210: 307-313. 10.1620/tjem.210.307.
Article
CAS
PubMed
Google Scholar
Warner J, Lessell S: Neuro-ophthalmology of multiple sclerosis. Clin Neurosci. 1994, 2: 180-188.
CAS
PubMed
Google Scholar
Merle H, Olindo S, Bonnan M, Donnio A, Richer R, Smadja D, Cabre P: Natural history of the visual impairment of relapsing neuromyelitis optica. Ophthalmology. 2007, 114: 810-815. 10.1016/j.ophtha.2006.06.060.
Article
PubMed
Google Scholar
Naismith RT, Tutlam NT, Xu J, Klawiter EC, Shepherd J, Trinkaus K, Song SK, Cross AH: Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis. Neurology. 2009, 72: 1077-1082. 10.1212/01.wnl.0000345042.53843.d5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mandler RN, Davis LE, Jeffery DR, Kornfeld M: Devic's neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol. 1993, 34: 162-168. 10.1002/ana.410340211.
Article
CAS
PubMed
Google Scholar
Lucchinetti CF, Parisi J, Bruck W: The pathology of multiple sclerosis. Neurol Clin. 2005, 23: 77-105. 10.1016/j.ncl.2004.09.002.
Article
PubMed
Google Scholar
Misu T, Fujihara K, Kakita A, Konno H, Nakamura M, Watanabe S, Takahashi T, Nakashima I, Takahashi H, Itoyama Y: Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain. 2007, 130: 1224-1234. 10.1093/brain/awm047.
Article
CAS
PubMed
Google Scholar
Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF: Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain. 2007, 130: 1194-1205. 10.1093/brain/awl371.
Article
PubMed
Google Scholar
Nagelhus EA, Veruki ML, Torp R, Haug FM, Laake JH, Nielsen S, Agre P, Ottersen OP: Aquaporin-4 water channel protein in the rat retina and optic nerve: polarized expression in Müller cells and fibrous astrocytes. J Neurosci. 1998, 18: 2506-2519.
CAS
PubMed
Google Scholar
Guy J, Rao NA: Acute and chronic experimental optic neuritis. Alteration in the blood-optic nerve barrier. Arch Ophthalmol. 1984, 102: 450-454.
Article
CAS
PubMed
Google Scholar
Hofman P, Hoyng P, vanderWerf F, Vrensen GF, Schlingemann RO: Lack of blood-brain barrier properties in microvessels of the prelaminar optic nerve head. Invest Ophthalmol Vis Sci. 2001, 42: 895-901.
CAS
PubMed
Google Scholar
Graber DJ, Levy M, Kerr D, Wade WF: Neuromyelitis optica pathogenesis and aquaporin 4. J Neuroinflammation. 2008, 5: 22-10.1186/1742-2094-5-22.
Article
PubMed
PubMed Central
Google Scholar
Gerling J, Meyer JH, Kommerell G: Visual field defects in optic neuritis and anterior ischemic optic neuropathy: distinctive features. Graefes Arch Clin Exp Ophthalmol. 1998, 236: 188-192. 10.1007/s004170050062.
Article
CAS
PubMed
Google Scholar
Levin LA, Rizzo JF, Lessell S: Neural network differentiation of optic neuritis and anterior ischaemic optic neuropathy. Br J Ophthalmol. 1996, 80: 835-839. 10.1136/bjo.80.9.835.
Article
CAS
PubMed
PubMed Central
Google Scholar
Green AJ, Cree BAC: Distinctive retinal nerve fibre layer and vascular changes in neuromyelitis optica following optic neuritis. J Neurol Neurosurg Psychiatry. 2009, 80: 1002-1005. 10.1136/jnnp.2008.166207.
Article
CAS
PubMed
Google Scholar
Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF: Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain. 2007, 130: 1194-1205. 10.1093/brain/awl371.
Article
PubMed
Google Scholar
Pirko I, Blauwet LK, Lesnick TG, Weinshenker BG: The natural history of recurrent optic neuritis. Arch Neurol. 2004, 61: 1401-1405. 10.1001/archneur.61.9.1401.
Article
PubMed
Google Scholar
Matiello M, Lennon VA, Jacob A, Pittock SJ, Lucchinetti CF, Wingerchuk DM, Weinshenker BG: NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology. 2008, 70: 2197-2200. 10.1212/01.wnl.0000303817.82134.da.
Article
CAS
PubMed
Google Scholar